Related Experiment Video
Updated: Jun 19, 2026
07:59
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
[When do combinations of diuretics make sense?].
1Universitätsklinik für Nephrologie und Hypertonie, Inselspital, Bern. daniel.fuster@insel.ch
Therapeutische Umschau. Revue Therapeutique
|November 4, 2009
Summary
Combining diuretic classes is essential for managing fluid volume and correcting side effects like hypokalemia. Understanding diuretic pharmacokinetics and molecular targets ensures safe and effective drug combinations for optimal patient outcomes.
Area of Science:
- Pharmacology
- Nephrology
- Clinical Medicine
Background:
- Diuretics are frequently prescribed to reduce extracellular fluid (ECF) volume.
- Combining diuretic classes is clinically relevant in specific scenarios.
Purpose of the Study:
- To outline the clinical situations where combining different classes of diuretics is indicated.
- To emphasize the importance of understanding diuretic pharmacokinetics and molecular targets for effective combination therapy.
Main Methods:
- Review of clinical scenarios requiring diuretic combinations.
- Discussion of pharmacokinetic and pharmacodynamic principles of diuretic classes.
Main Results:
- Combination therapy is beneficial when maximal doses of a single diuretic fail to achieve sufficient diuresis.
- Combining diuretics can effectively counteract side effects, such as hypokalemia induced by loop or thiazide diuretics, by adding potassium-sparing agents.
Conclusions:
- Judicious combination of diuretics requires a thorough understanding of their individual properties.
- Knowledge of pharmacokinetics and molecular targets is crucial for optimizing diuretic combination therapy and patient management.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:16Antihypertensive Drugs: Action of Diuretics
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...